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Supplementary Table S1; LC-MS/MS results for the proteins, potentially interacting with TDP-43 during ubiquitination.
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Recombinant TDP-43-FLAG proteins were incubated with reaction buffer containing all components for in vitro ubiquitination. After adding 
disulfide cross-linker, dithiobis[succinimidyl propionate] (DSP), reaction mixture was incubated with anti-FLAG affinity beads. After releasing 
from TDP-43 under the mild reducing conditions, protein pulled-down with TDP-43 were trypsinized and analyzed by LC-MS/MS. The acquired 
MS/MS spectra were automatically searched against the protein database in NCBI using the TurboSEQUEST. P, peptide probability. Sf, Sf-Final 
score. 
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Supplementary Table S2 
 
pcDNA3-TDP-43-FLAG forward 5’-TGCGCAGTCTCTTTGTGGACAGGACTTGATCATTA-3’ 
E246Q reverse 5’-TAATGATCCTGTCCACAAAGAGACTGCGCA-3’
pcDNA3-TDP-43-FLAG forward 5'-CGCAGTCTCTTTGTGGAGAGAACTTGATCATTAAAGGAATC-3’
D247N reverse 5'-GATTCCTTTAATGATCAAGTTCTCTCCACAAAGAGACTGCG-3’
pcDNA3-TDP-43-FLAG forward 5'-TGATCAGTGTGGAGAGGACTTGAT-3’
ǻ1(6 reverse 5'-TCTCCACACTGATCATCTGCAAATG-3’
pcDNA3-TDP-43-FLAG forward 5'-TGGAGAGAAAGGAATCAGCGTTCAT-3’
ǻ1(6 reverse 5'-ATTCCTTTCTCTCCACAAAGAGACTG-3’
pcDNA3-TDP-43-FLAG forward 5'-TACCGAGCTCGGATCCAAGATGGCTTCATCAGCAG-3’
CTF35 reverse 5'-TAGATGCATGCTCGAGTCACTTGTCGTCATCGTCT-3’
forward 5'-GGGGGATCCGTTCTTTGAAACCAAGAGTAGTAG-3’
reverse 5'-CCCGGTACCTCACGCGACGTAC|GCTGTATT-3’
forward 5'-GGGAAGCTTGATGCCCCGGAGGGCGGAGAACTGGGA-3’
reverse 5'-CCCGAATTCAATCTCCCATCCGTTGAT-3’
forward 5'-GGUGCAGACUAUAUGGACUGCUUAU-3’
reverse 5'-AUAAGCAGUCCAUAUAGUCUGCACC-3’
forward 5'-GGUAUCUCAACACCCAGUUUAUUAA-3’
reverse 5'-UUAAUAAACUGGGUGUUUGAGAUACC-3’
forward 5'-CAGAGAACCUAAGUCUGUUUGCAAA-3䈓
reverse 5'- UUUGCAAACAGACUUAGGUUCUCUG-3䈓.
forward 5'-AAGACUUAGAAUCCAUGCUUGAGCC-3’
reverse 5'-GGCUCAAGCAUGGAUUCUAAGUCUU-3’
forward 5'-UUUCACUGCUGAUGAAGCAUCUGUC-3’
reverse 5'-GACAGAUGCUUCAUCAGCAGUGAAA-3’ 
forward 5'-UGAAUGACCAGUCUUAAGAUCUUUC-3’
reverse 5'-GAAAGAUCUUAAGACUGGUCAUUCA-3’
forward 5'-TACCGAGGTCACCTTTGGCTC-3’
reverse 5'-TCTCCCATCCGTTGATGTG-3’ 
forward 5'-GCACCGTCSSGGCTGAGAAC-3’
reverse 5'-TGGTGGTGAAGACGCCAGTGGA -3’
Cloning primer pairs
siRNA
pcDNA3-Myc-CUL2 
GAPDH
real time-PCR
pcDNA3-HA-VHL 
CUL2_#1
CUL2_#2
CUL2_#3
TDP-43_#1
TDP-43_#2
TDP-43_#3
VHL
 
Sequence information of oligonucleotides for cloning, siRNA, and real-time PCR
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Supplementary Table S3 
 
Antigen (clone) Company origin ICC IHC IB
FLAG (M2) SIGMA mouse 1:500 N.A. 1:500
HA (3F10) Roche rat 1:300 N.A. 1:500
GFP Nacalai tesque rat N.A. N.A. 1:500
TARDBP Proteintech rabbit 1:500 1:500 1:500
CUL2 Abcam rabbit 1:200 N.A. 1:500
VHL Thermo-Fischer rabbit N.A. N.A. 1:500
ElonginB Santa Cruz rabbit N.A. N.A. 1:500
ElonginC Santa Cruz rabbit N.A. N.A. 1:500
ubiquitin K48 Milipore rabbit 1:500 N.A. 1:500
Hsc70/Hsp70 StressGen rabbit 1:200 N.A. 1:500
phospho-TDP-43 Cosmobio rabbit N.A. 1:300 N.A.
GST-pi MBL rabbit N.A. 0.1805556 N.A.
3'*)5Į Santa Cruz rabbit N.A. N.A. 1:500
MBP MBL International rabbit N.A. N.A.
GAPDH Santa Cruz rabbit N.A. N.A. 1:500
actin Santa Cruz mouse N.A. N.A. 1:1000
VHL self-made mouse 1:500 1:100 1:400
TDP-43(3B12A) self-made mouse 1:500 N.A. N.A.
MBP; myelin basic protein; GST-pi; glutahione S-trensferase -pi
3'*)5Į3ODWHOHW'HULYHG*URZWK)DFWRU5HFHSWRU$OSKD3RO\SHSWLGH
ICC, immunocytochemistry; IHC immunohistochemistry; IB, immunoblotting.
N.A. indicates "not assessed"  
 
Antibody information used in this work. ICC, immunocytochemistry; IHC 
immunohistochemistry; IB, immunoblotting. N.A. indicates "not assessed".
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Supplementary Figure S1 
 
Confocal laser microscope analysis showing the colocalization of WT TDP-43 and 
endogenous VHL. HEK293A cells were transiently transfected with TDP-43-FLAG
with (e-h, m-p) or without (a-d, i-l) HA-VHL. After 48 h, cells were fixed and
immunostained for FLAG (green) and VHL (red). Arrowheads indicates perinuclear 
inclusions of WT TDP-43, which are also immunoreactive to VHL. Scale bar = 20 μm.
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Supplementary Figure S2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The binding affinity of FALS-linked TDP-43 with VHL.  HeLa cells were 
transiently transfected with TDP-43-FLAG (WT, A315T, G331K) and HA-VHL. Cell 
lysates harvested 48 h after transfection were immunoprecipitated with anti-HA 
antibody, and analyzed by Western blotting for TDP-43 or FLAG. Note that 
FALS-linked TDP-43 displayed comparative binding with VHL.
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Supplementary Figure S3 
 
Confocal laser microscope analysis showing the colocalization pattern of WT or 
mutant TDP-43,  ubiquitin, and HA-VHL. HEK293A cells were transiently 
transfected with TDP-43-EGFP (WT, C175S, C173S/C175S, mNLS) or GFP vector 
control and HA-VHL. After 48 h, cells were fixed and immunostained for ubiquitin K48 
(blue) and HA (red). Arrowheads indicates perinuclear inclusions of TDP-43 and 
ubiquitin, which are also immunoreactive to overexpressed VHL. Scale bar = 20 μm. 
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Supplementary Figure S4 
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CUL2 colocalizes with aggregated TDP-43. Fluorescence microscope of HeLa cells 
expressing FLAG-CUL2 and TDP-43-EGFP of WT (a-e), mNLS (e-f), and double 
mutants with defective NLS and with substitutions at Cys173S for Ser (mNLS-C173S, 
i-l). Cells were fixed and immunostained for FLAG (red).
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Supplementary Figure S5 
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Confocal microscope analysis showing the E246/D247 is exposed in the 
aggregate-prone TDP-43. TDP-43. HEK293A cells were transfected with WT or 
C173S/C175S mutant of TDP-43-EGFP with or without mutant nucleus localizing 
signal (NLS). After 48 h, cells were fixed and were immunostained for 3B12A MAb, 
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raised against E246/D246 as a core epitope. Note that 3B12A recognizes only 
milocaized (m-p), aggregate-prone TDP-43 eiher in nucleus (i-l) or cytosol (q-t), but not 
WT TDP-43 (e-h) or EGFP (a-GSURWHLQV6FDOHEDU ȝP
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Supplementary Figure S6 
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TDP-43 is mechanically fragile and readily fragmented in vitro. A. GST-tagged 
full-length TDP-43-FLAG proteins were induced by IPTG in E coli, and GST was
released from TDP-43 by protease. a. The recombinant TDP-43 before (left panels) and 
after (right panels) protease treatment was analyzed with Western blotting, using 
antibodies against TDP-43 and FLAG. b. Recombinant FL TDP-43-FLAG and 
CTF35-FLAG, being stored at -Û&, immediately after protease cleavage and buffer 
replacement, were separated onto polyacrylamide gel, and were visualized with 
Coomassie brilliant blue (CBB), anti-TDP-43, and anti-FLAG antibodies. Note that 
smaller fragments, containing N-sided (by ant-TDP-43(108-116) and C terminal were 
ones, were abundantly detected, even in the carefully frozen condition.
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Supplementary Figure S7 
Effect of VHL overexpression on the aggregate formation of TDP-43 in HEK293A 
cells. HEK293A cells were transiently co-transfected with TDP-43-EGFP ((a) and (b) 
for WT, (c) and (d) for C175S) and HA-VHL or vector control. Forty-eight h after the 
transfection, cells were fixed with 4% PFA, and at least four photos containing more 
than 100 cells/image were randomly obtained, and analyzed unbiasedly, using image-J
software. Arrows indicate counted cells with TDP-43 aggregates. 
-13- 
 
 
Supplementary Figure S8 
Confocal microscope analysis showing that TDP-43 inclusions co-localize with 
VHL and Hsp70.
HEK293A cells were transiently co-transfected with TDP-43-EGFP and HA-VHL. 
After 48 h, cells were fixed and immunostained for HA (red) and Hsp70 (blue). 
TDP-43-(*)3LVLQGLFDWHGLQJUHHQ6FDOHEDU ȝP
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Supplementary Figure S9 
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Colocalization of phosphorylated TDP-43 and VHL in the oligodendrocytes in 
ALS.  Immunohistochemistry of spinal oligodendrocytes for VHL in the spinal cords 
from ALS patients (b-r) and ALS-irrelevant control subjects (a). In (b), cytoplasmic 
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aggregates of VHL in oligodendrocytes are indicated by arrowheads, glial cytoplasmic 
inclusions were magnified in the insets (A-E), (c-r) Double immunofluorescence 
study shows that the VHL colocalize with GST-pi (c-f, g-j), and with phosphorylated 
TDP-43 (k-n, o-r) in cytoplasmic inclusions in oligodendrocytes (arrows).Scale 
EDU ȝP  
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Supplementary Figure S10 
Effect of VHL overexpression on the aggregate formation of mutant SOD1 in 
HEK293A cells. HEK293A cells were transiently co-transfected with human 
SOD1-EGFP ((a) and (b) for WT, (c) and (d) for G93A) and HA-VHL or vector 
control. Forty-eight hr after the transfection, cells were fixed with 4% PFA, and at least 
four photos containing more than 50 cells/image were randomly obtained, and 
analyzed unbiasedly, using image-J software. Arrows indicate counted cells with 
SOD1 aggregates. 
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Supplementary Figure S11 
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Original Western blots of trimmed panels in Fig. 1. 
Supplementary Figure S12 
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Supplementary Figure S13 
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Original Western blots of trimmed panels in Fig. 3. 
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Supplementary Figure S14 
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Supplementary Figure S15 
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Supplementary Figure S16 
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Supplementary Figure S17 
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Supplementary Figure S18 
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Original Western blots of trimmed panels in Fig. 9
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Supplementary Figure S19 
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